ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65 | -90.7% | 66,770 | -86.7% | 0.00% | -85.7% |
| Q2 2023 | $696 | +2220.0% | 500,769 | +2478.2% | 0.01% | – |
| Q1 2023 | $30 | -75.6% | 19,423 | -2.2% | 0.00% | -100.0% |
| Q4 2022 | $123 | -100.0% | 19,856 | -57.0% | 0.00% | -33.3% |
| Q3 2022 | $309,000 | +45.8% | 46,195 | +38.0% | 0.00% | +50.0% |
| Q2 2022 | $212,000 | -82.0% | 33,466 | -85.8% | 0.00% | -71.4% |
| Q4 2021 | $1,177,000 | -47.1% | 235,475 | +27.5% | 0.01% | -50.0% |
| Q3 2021 | $2,225,000 | +448.0% | 184,684 | +2606.0% | 0.01% | -17.6% |
| Q4 2019 | $406,000 | – | 6,825 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |